Other Clinical Trial - Supplementary Food on Prevention of Moderate

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The study will evaluate the impact of a supplementary food (cookies) in preventing the risk of developing moderate acute malnutrition (MAM) in preschool mildly malnourished children.

Children will be divided in two groups; one will received the cookie plus 12 educative sessions and the other just the educative program. The study will last 12 months

NCT number	NCT02572258
Study type	Interventional
Source	PepsiCo Global R&D
Contact
Status	Completed
Phase	N/A
Start date	September 2015
Completion date	September 2017

	Status	Clinical Trial	Phase
	Completed	`NCT01015950` - Management of Children With Moderate Acute Malnutrition in Mali	N/A
	Terminated	`NCT02077907` - Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition (MAM) in Children in Sierra Leone: a Cluster-randomised, Controlled Clinical Effectiveness Trial	N/A

Supplementary Food on Prevention of Moderate Malnutrition in Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms